MiR-518c-5p/miR-4524a-3p can mediate immune escape and chemotherapy resistance in triple-negative breast cancer and predict its outcome
MiR-518c-5p/miR-4524a-3p contribute to TNBC progression by facilitating immune evasion and chemoresistance. Targeting miR-518c-5p/miR-4524a-3p may represent a promising therapeutic approach for improving TNBC treatment outcomes.
Authors
- Pengfei Qian (ORCID: https://orcid.org/0000-0001-7320-5777)
- Linna Kong
- Jiaqi Liu (ORCID: https://orcid.org/0009-0004-6391-7454)
- Xiaoyan Liu (ORCID: https://orcid.org/0000-0002-6448-2008)
- Huihui Zhang (ORCID: https://orcid.org/0000-0002-3210-4176)
- Yuan Sun (ORCID: https://orcid.org/0000-0001-9742-8916)
- Liang An (ORCID: https://orcid.org/0000-0002-5466-7834)
Institutions
- Qujing Normal University (CN)
- Shanghai Cancer Institute (CN)
- Huizhou Central People's Hospital (CN)
- Central Hospital of Zibo (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1186/s41065-025-00572-8
- Citations
- 1
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.94